Barry Gumbiner

Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia

Claude Gagné, Harold Bays, Stuart Weiss et al. · The American Journal of Cardiology · 2002 · 493 citations

Primary Hypercholesterolemia, Lipid Disorder, Cardiovascular Disease +7

Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia

Saskia de Jongh, Leiv Ose, Tamás Szamosi et al. · Circulation · 2002 · 308 citations

Intensive Conventional Insulin Therapy for Type II Diabetes: Metabolic effects during a 6-mo outpatient trial

Robert R. Henry, Barry Gumbiner, Timothy M. Ditzler et al. · Diabetes Care · 1993 · 231 citations

The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake

Carol Addy, Hamish Wright, Koen Van Laere et al. · Cell Metabolism · 2008 · 200 citations · Full text

Obesity, Metabolic Syndrome, Caloric Restriction +11

Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.

A W Thorburn, Barry Gumbiner, F Bulacan et al. · Journal of Clinical Investigation · 1990 · 185 citations · Full text

Nutrition, Glycogen Synthase Activity, Type Ii +19